Stockscreener 앱 받기
2.53
5.24%
-0.14
시간 외 거래:
2.57
0.04
+1.58%
전일 마감가:
$2.67
열려 있는:
$2.69
하루 거래량:
4.16M
Relative Volume:
1.08
시가총액:
$392.45M
수익:
-
순이익/손실:
$-110.78M
주가수익비율:
-2.3645
EPS:
-1.07
순현금흐름:
$-75.59M
1주 성능:
+8.58%
1개월 성능:
+15.53%
6개월 성능:
-45.12%
1년 성능:
-68.96%
1일 변동 폭
$2.44
$2.70
1주일 범위
$2.28
$2.82
52주 변동 폭
$1.15
$9.79
Humacyte Inc Stock (HUMA) Company Profile
명칭
Humacyte Inc
전화
919-313-9633
주소
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
HUMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
2.53 | 414.17M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 재개 | H.C. Wainwright | Buy |
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-11 | 개시 | H.C. Wainwright | Buy |
| 2023-08-14 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-16 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 개시 | Cowen | Outperform |
| 2021-09-24 | 개시 | Oppenheimer | Outperform |
| 2021-09-22 | 개시 | BTIG Research | Buy |
| 2021-09-16 | 개시 | Piper Sandler | Overweight |
모두보기
Humacyte Inc 주식(HUMA)의 최신 뉴스
What institutional investors are buying Humacyte Inc. stockCapitalize on market momentum for maximum profit - jammulinksnews.com
Does Humacyte Inc. Equity Warrant stock perform well during market downturnsMaximize portfolio returns with smart trading - jammulinksnews.com
How strong is Humacyte Inc. Equity Warrant company’s balance sheetMassive wealth growth - jammulinksnews.com
How does Humacyte Inc. compare to its industry peersSuperior trading gains - jammulinksnews.com
What catalysts could drive Humacyte Inc. Equity Warrant stock higher in 2025Market-leading growth rates - jammulinksnews.com
When is Humacyte Inc. Equity Warrant stock expected to show significant growthSkyrocketing investment returns - jammulinksnews.com
How does Humacyte Inc. generate profit in a changing economyUnlock exclusive stock market insights - jammulinksnews.com
Should I hold or sell Humacyte Inc. stock in 2025Capitalize on fast-growing investment opportunities - jammulinksnews.com
What are Humacyte Inc. company’s key revenue driversInvest confidently with professional market insights - jammulinksnews.com
Is Humacyte Inc. a growth stock or a value stockDiscover dynamic stocks ready to soar - jammulinksnews.com
Why is Humacyte Inc. Equity Warrant stock attracting strong analyst attentionMaximize your gains with expert trading tips - jammulinksnews.com
When is Humacyte Inc. stock expected to show significant growthUnlock the power of real-time market data - jammulinksnews.com
Is Humacyte Inc. stock overvalued or undervaluedBuild a portfolio for long-term financial success - jammulinksnews.com
Humacyte Inc. Stock Analysis and ForecastExplosive trading opportunities - PrintWeekIndia
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
What drives Humacyte Inc. stock priceExceptional return forecasts - PrintWeekIndia
Humacyte Inc. Equity Warrant Stock Analysis and ForecastDynamic profit expansion - PrintWeekIndia
What analysts say about Humacyte Inc. Equity Warrant stockOutstanding investment returns - PrintWeekIndia
Will Humacyte Inc. Equity Warrant stock benefit from AI tech trendsBreakout stock performance - jammulinksnews.com
Humacyte, Inc. (HUMA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Humacyte rises on Symvess sale to military treatment facility - MSN
Would Humacyte (NASDAQ:HUMA) Be Better Off With Less Debt? - 富途牛牛
Humacyte stock rises after first Symvess sale to US Military facility - Investing.com
What drives Humacyte Inc. Equity Warrant stock priceExplosive trading opportunities - Autocar Professional
Humacyte, Inc. shares rise 1.47% after-hours after announcing first Symvess sale to U.S. Military Treatment Facility. - AInvest
Humacyte shares climb 6% after first Symvess sale to U.S. military hospital - MSN
Is Humacyte Inc. Equity Warrant a good long term investmentUnprecedented profit potential - Autocar Professional
Humacyte stock rises after first Symvess sale to US Military facility By Investing.com - Investing.com South Africa
Humacyte Announces First Symvess™ Sale to Military Treatment Facility - The Manila Times
What analysts say about Humacyte Inc. stockMassive profits - jammulinksnews.com
Is Humacyte Inc. a good long term investmentOutstanding risk-reward balance - jammulinksnews.com
Humacyte Inc (HUMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
0.22%
자본화:
|
볼륨(24시간):